Jubilant Radiopharma Competitors and Similar CompaniesClear all

Jubilant Radiopharma's competitors and similar companies include Roche, Taejoon, Dong-A Socio Holdings and Almac Group.

	Jubilant Radiopharma Jubilant Radiopharma (also known as Jubilant DraxImage) is a company that provides pharmaceutical solutions.	Roche Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.	Taejoon Taejoon is a pharmaceutical company.	Dong-A Socio Holdings Dong-A Socio Holdings (동아쏘시오홀딩스, also known as Dong-A ST) is a company that manufactures and sells pharmaceuticals.	Almac Group Almac Group is a company that provides a range of services across the drug development lifecycle.
Founding Date	Founding Date 1955	Founding Date 1896	Founding Date 1978	Founding Date 1932	Founding Date 2002
Type	Type Subsidiary	Type Public	Type Private	Type Public	Type Subsidiary
Tags	Tags Healthcare drug development medical diagnostics pharma	Tags Healthcare biotech drug development medical diagnostics pharma	Tags Healthcare drug development medical diagnostics pharma	Tags Healthcare drug development medical diagnostics pharma	Tags Healthcare chemicals clinical research drug development pharma
Locations	Locations Kirkland, CA HQ Noida, IN	Locations Basel, CH HQ Hydra, DZ Ricardo Rojas, AR North Ryde, AU Sydney, AU Wien, AT Dhaka, BD see more	Locations HQ	Locations Seoul, KR HQ Sao Paulo, BR Cerritos, US	Locations Craigavon, GB HQ Athlone, IE Dundalk, IE Minato City, JP Singapore, SG Alderley Edge, GB Belfast, GB see more
Employees	Employees 1381% increase	Employees 103,249	Employees 52	Employees 922% increase	Employees 4,7021% increase
Financial
Revenue (est.)	Revenue (est.) N/A	Revenue (est.) CHF61.5b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₩1.4t (FY, 2025)	Revenue (est.) £735.1m (FY, 2021)
Cost of goods	Cost of goods N/A	Cost of goods CHF13.1b (FY, 2025)	Cost of goods N/A	Cost of goods ₩894.9b (FY, 2025)	Cost of goods £474.7m (FY, 2021)
Gross profit	Gross profit N/A	Gross profit CHF50.5b (FY, 2025)	Gross profit N/A	Gross profit ₩542.4b (FY, 2025)	Gross profit £260.3m (FY, 2021)
Net income	Net income N/A	Net income CHF13.8b (FY, 2025)	Net income N/A	Net income ₩91.5b (FY, 2025)	Net income £64.2m (FY, 2021)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 7.8b	Total funding raised N/A	Total funding raised N/A	Total funding raised $ 1m